EXPIRATORY RESERVE VOLUME DECREASED

This adverse event was reported 63 times

These drugs are most commonly taken by patients reporting EXPIRATORY RESERVE VOLUME DECREASED:

# Drug Count
0 PREDNISONE 28
1 OMALIZUMAB 26
2 METFORMIN 23
3 METFORMIN ER 500 MG 23
4 METFORMIN ER 750 MG 23
5 ALBUTEROL SULFATE 22
6 FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE 22
7 ASPIRIN 21
8 ASPIRIN 325 MG 21
9 ASPIRIN 81 MG 21
See all common drugs associated with EXPIRATORY RESERVE VOLUME DECREASED

EXPIRATORY RESERVE VOLUME DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GLYCOPYRROLATE 8 0.0014
1 FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE 22 0.0006
2 CICLESONIDE 6 0.0004
3 IPRATROPIUM BROMIDE 15 0.0004
4 NEPAFENAC 1 0.0003
5 FLUOROMETHOLONE 1 0.0003
6 OMALIZUMAB 26 0.0003
7 MEPOLIZUMAB 14 0.0003
8 BRINZOLAMIDE/BRIMONIDINE TARTRATE 1 0.0002
9 GLIPIZIDE 14 0.0002
See all drugs enriched for association with EXPIRATORY RESERVE VOLUME DECREASED

EXPIRATORY RESERVE VOLUME DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 14 0.0203
1 Anti-IgE [EPC] 26 0.0003
2 Leukotriene Receptor Antagonist [EPC] 8 0.0003
3 Sulfonylurea [EPC] 14 0.0001
4 Quinolone Antimicrobial [EPC] 1 0.0001
5 Carbonic Anhydrase Inhibitor [EPC] 1 0.0000
6 Pyridone [EPC] 2 0.0000
7 Platelet Aggregation Inhibitor [EPC] 21 0.0000
8 Corticosteroid [EPC] 35 0.0000
9 Aminoglycoside Antibacterial [EPC] 1 0.0000
See all drug classes enriched for association with EXPIRATORY RESERVE VOLUME DECREASED